Mark L. Steinberg

Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial

Jean‐Marc Nabholtz, Aman U. Buzdar, Michaël Pollak et al. · Journal of Clinical Oncology · 2000 · 996 citations

Pharmacy, Oncology, Pharmacotherapy +15

Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study

Jacques Bonneterre, Beat Thürlimann, J.F.R. Robertson et al. · Journal of Clinical Oncology · 2000 · 840 citations

Medicine, Oncology, Pharmacology +15

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma

J. Bonneterre, Aman U. Buzdar, Jean‐Marc Nabholtz et al. · Cancer · 2001 · 575 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.

Aman U. Buzdar, W. Jonat, Anthony Howell et al. · PubMed · 1998 · 418 citations

Medicine, Oncology, Pharmacology +15

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma

Aman U. Buzdar, W. Jonat, Anthony Howell et al. · Cancer · 1998 · 172 citations

Pharmacy, Oncology, Pharmacotherapy +16